Analysis of BCR/ABL transcripts in healthy individuals

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 4967-4971

  Boquett, J A ^a   Alves, J R P ^b   de Oliveira, C E C ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto de Hematologia de Cascavel   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

BCR ABL; Chromosome rearrangements; Chronic myeloid leukemia

Indexed keywords

BCR ABL PROTEIN;

ADULT; ARTICLE; BCR ABL GENE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; RISK; VOLUNTEER; CHRONIC MYELOID LEUKEMIA; GENE TRANSLOCATION; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; FEMALE; FUSION PROTEINS, BCR-ABL; HEALTHY VOLUNTEERS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 84887288139     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.October.24.8     Document Type: Article

References (19)

1. Barbosa LP, Sousa JM, Simões FV, Bragança IC, et al. (2000). Análise de transcritos da translocação t(9;22) em leucemia mielóide crônica. Rev. Bras. Hematol. Hemoter. 22: 89-98.
2. Bayraktar S and Goodman M (2010). Detection of BCR-ABL Positive Cells in an Asymptomatic Patient: A Case Report and Literature Review. Case Rep. Med. 2010: 939706.
3. Biernaux C, Loos M, Sels A, Huez G, et al. (1995). Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86: 3118-3122.
4. Bose S, Deininger M, Gora-Tybor J, Goldman JM, et al. (1998). The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 92: 3362-3367.
5. Brassesco MS, Montaldi AP, Gras DE, de Paula Queiroz RG, et al. (2009). MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals. Genet. Mol. Biol. 32: 234-241.
6. Burke BA and Carroll M (2010). BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia. Leukemia 24: 1105-1112.
7. Corbin AS, Agarwal A, Loriaux M, Cortes J, et al. (2011). Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J. Clin. Invest. 121: 396-409.
8. Cosset E, Hamdan G, Jeanpierre S, Voeltzel T, et al. (2011). Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia. Blood 117: 1673-1676.
9. Di Bacco A, Keeshan K, McKenna SL and Cotter TG (2000). Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. Oncologist 5: 405-415.
10. Fernandez-Luna JL (2000). Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells. Apoptosis 5: 315-318.
11. Goldman JM, Green AR, Holyoake T, Jamieson C, et al. (2009). Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. Leukemia 23: 1708-1715.
12. Jackson SP and Bartek J (2009). The DNA-damage response in human biology and disease. Nature 461: 1071-1078.
13. Jilani I, Kantarjian H, Gorre M, Cortes J, et al. (2008). Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy. Leuk. Res. 32: 643-649.
14. Kurzrock R, Kantarjian HM, Druker BJ and Talpaz M (2003). Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann. Intern. Med. 138: 819-830.
15. Melo JV (1996). The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88: 2375-2384.
16. Nguyen T, Dai Y, Attkisson E, Kramer L, et al. (2011). HDAC inhibitors potentiate the activity of the BCR/ABL kinase inhibitor KW-2449 in imatinib-sensitive or-resistant BCR/ABL+ leukemia cells in vitro and in vivo. Clin. Cancer Res. 17: 3219-3232.
17. Nowell PC and Hungerford DA (1960). A minute chromosome in human chronic granulocytic leukemia. Science 132: 1497-1501.
18. Rowley JD (1973). Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290-293.
19. Saglio G, Pane F, Gottardi E, Frigeri F, et al. (1996). Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 87: 1075-1080.